Your browser doesn't support javascript.
loading
Fibroblast activation protein (FAP) as a novel metabolic target.
Sánchez-Garrido, Miguel Angel; Habegger, Kirk M; Clemmensen, Christoffer; Holleman, Cassie; Müller, Timo D; Perez-Tilve, Diego; Li, Pengyun; Agrawal, Archita S; Finan, Brian; Drucker, Daniel J; Tschöp, Matthias H; DiMarchi, Richard D; Kharitonenkov, Alexei.
Afiliação
  • Sánchez-Garrido MA; Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center, Munich, 85748, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, 85748, Germany; German Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
  • Habegger KM; Department of Medicine Endocrinology, Diabetes & Metabolism, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Clemmensen C; Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center, Munich, 85748, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, 85748, Germany; German Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
  • Holleman C; Department of Medicine Endocrinology, Diabetes & Metabolism, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
  • Müller TD; Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center, Munich, 85748, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, 85748, Germany; German Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
  • Perez-Tilve D; Division of Endocrinology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, 45237, United States.
  • Li P; Department of Chemistry, Indiana University, Bloomington, IN, 46405, United States.
  • Agrawal AS; Department of Chemistry, Indiana University, Bloomington, IN, 46405, United States.
  • Finan B; Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center, Munich, 85748, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, 85748, Germany; German Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
  • Drucker DJ; Lunenfeld Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, 600 University Ave, TCP5-1004 Mailbox 39, Toronto, Ontario, M5G 1X5, Canada.
  • Tschöp MH; Institute for Diabetes and Obesity (IDO), Helmholtz Diabetes Center, Munich, 85748, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, Munich, 85748, Germany; German Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
  • DiMarchi RD; Department of Chemistry, Indiana University, Bloomington, IN, 46405, United States. Electronic address: rdimarch@indiana.edu.
  • Kharitonenkov A; Department of Chemistry, Indiana University, Bloomington, IN, 46405, United States. Electronic address: alexkhar@indiana.edu.
Mol Metab ; 5(10): 1015-1024, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27689014
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article